Literature DB >> 35178186

Hydrophobic Tagging-Induced Degradation of PDEδ in Colon Cancer Cells.

Menglu Guo1, Shipeng He2, Junfei Cheng1, Yu Li1, Guoqiang Dong1, Chunquan Sheng1.   

Abstract

The development of KRAS-PDEδ protein-protein interaction (PPI) inhibitors is generally hampered by limited antitumor activity. Herein, the first hydrophobic tagging (HyT)-based PDEδ degraders were designed. Compound 17c efficiently bound to PDEδ and induced degradation of PDEδ in SW480 colon cancer cells. As compared with PDEδ inhibitor deltazinone, HyT-based degrader 17c exhibited improved antitumor activity toward KRAS mutant cancer cells. This study highlighted the potential of HyT as a valuable chemical tool for tumorigenic PDEδ knockdown, which could be developed into a promising strategy for antitumor drug discovery.
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 35178186      PMCID: PMC8842115          DOI: 10.1021/acsmedchemlett.1c00670

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  27 in total

Review 1.  Drugging the undruggable RAS: Mission possible?

Authors:  Adrienne D Cox; Stephen W Fesik; Alec C Kimmelman; Ji Luo; Channing J Der
Journal:  Nat Rev Drug Discov       Date:  2014-10-17       Impact factor: 84.694

Review 2.  Structure-based development of PDEδ inhibitors.

Authors:  Pablo Martín-Gago; Eyad Kalawy Fansa; Alfred Wittinghofer; Herbert Waldmann
Journal:  Biol Chem       Date:  2017-05-01       Impact factor: 3.915

Review 3.  Targeting Mutant KRAS for Anticancer Therapy.

Authors:  Fengqian Chen; Martin P Alphonse; Yan Liu; Qi Liu
Journal:  Curr Top Med Chem       Date:  2019       Impact factor: 3.295

4.  Structural Biology-Inspired Discovery of Novel KRAS-PDEδ Inhibitors.

Authors:  Yan Jiang; Chunlin Zhuang; Long Chen; Junjie Lu; Guoqiang Dong; Zhenyuan Miao; Wannian Zhang; Jian Li; Chunquan Sheng
Journal:  J Med Chem       Date:  2017-10-03       Impact factor: 7.446

5.  Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.

Authors: 
Journal:  Cancer Cell       Date:  2017-08-14       Impact factor: 31.743

Review 6.  Induced protein degradation: an emerging drug discovery paradigm.

Authors:  Ashton C Lai; Craig M Crews
Journal:  Nat Rev Drug Discov       Date:  2016-11-25       Impact factor: 84.694

7.  Genomic Classification of Cutaneous Melanoma.

Authors: 
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

8.  Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging.

Authors:  Jeffrey L Gustafson; Taavi K Neklesa; Carly S Cox; Anke G Roth; Dennis L Buckley; Hyun Seop Tae; Thomas B Sundberg; D Blake Stagg; John Hines; Donald P McDonnell; John D Norris; Craig M Crews
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-17       Impact factor: 15.336

Review 9.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

10.  Drugging an undruggable pocket on KRAS.

Authors:  Dirk Kessler; Michael Gmachl; Andreas Mantoulidis; Laetitia J Martin; Andreas Zoephel; Moriz Mayer; Andreas Gollner; David Covini; Silke Fischer; Thomas Gerstberger; Teresa Gmaschitz; Craig Goodwin; Peter Greb; Daniela Häring; Wolfgang Hela; Johann Hoffmann; Jale Karolyi-Oezguer; Petr Knesl; Stefan Kornigg; Manfred Koegl; Roland Kousek; Lyne Lamarre; Franziska Moser; Silvia Munico-Martinez; Christoph Peinsipp; Jason Phan; Jörg Rinnenthal; Jiqing Sai; Christian Salamon; Yvonne Scherbantin; Katharina Schipany; Renate Schnitzer; Andreas Schrenk; Bernadette Sharps; Gabriella Siszler; Qi Sun; Alex Waterson; Bernhard Wolkerstorfer; Markus Zeeb; Mark Pearson; Stephen W Fesik; Darryl B McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.